Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Neratinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 15,073Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New Breast Cancer Therapy Cuts Recurrence Risk in Thailand
    New Breast Cancer Therapy Cuts Recurrence Risk in Thailand

    22 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-breast-cancer-therapy-to-reduce-risk-of-recurrence-and-improve-disease-free-survival-now-available-in-thailand-302666471.html

    PR NEWSWIRE
    22 Jan 2026
    Share Share
    Er-Kim partners with Puma Biotech to distribute Nerlynx
    Er-Kim partners with Puma Biotech to distribute Nerlynx

    30 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/30/3071101/0/en/Er-Kim-Announces-Exclusive-Distribution-Agreement-with-Puma-Biotechnology-to-Commercialize-NERLYNX-neratinib-for-Breast-Cancer-Patients.html

    GLOBENEWSWIRE
    30 Apr 2025
    Share Share
    Puma Biotech Presents Neratinib Data at AACR Meeting 2025
    Puma Biotech Presents Neratinib Data at AACR Meeting 2025

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428437683/en/Puma-Biotechnology-Presents-Clinical-Data-on-Neratinib-at-the-AACR-Annual-Meeting-2025

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Puma to Present Neratinib Data at AACR Annual Meeting 2025
    Puma to Present Neratinib Data at AACR Annual Meeting 2025

    26 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250326003684/en/Puma-Biotechnology-to-Present-Clinical-Data-on-Neratinib-at-the-AACR-Annual-Meeting-2025

    BUSINESSWIRE
    26 Mar 2025
    Share Share
    Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial
    Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial

    07 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221207005734/en

    BUSINESSWIRE
    07 Dec 2022
    Share Share
    Puma Biotechnology Presents Updated Findings from the PII Trial of Neratinib
    Puma Biotechnology Presents Updated Findings from the PII Trial of Neratinib

    27 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221027005333/en

    BUSINESSWIRE
    27 Oct 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.